A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19

BACKGROUND: Traditional knowledge and scientific shreds of evidence strongly support the repurpose of Kalmegh (Andrographis paniculata, CIM-MEG19) as an alternate therapy for prophylactic management and treatment of severe acute respiratory syndrome coronavirus (SARS-CoV) and associated health disor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanker, Karuna, Rangnekar, Hrishikesh, Wele, Asmita, Soni, Pravin, Gaikwad, Pranesh, Pal, Anirban, Bawankule, Dnyaneshwar U., Chanda, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762910/
https://www.ncbi.nlm.nih.gov/pubmed/36570418
http://dx.doi.org/10.1016/j.phyplu.2022.100398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762910/
https://www.ncbi.nlm.nih.gov/pubmed/36570418
http://dx.doi.org/10.1016/j.phyplu.2022.100398

Ejemplares similares